Stock-Based Compensation Expense

A stock-based compensation expense (or SABE) is the dollar amount that a company records on its income statement to reflect the cost of granting equity to employees. Under ASC 718, the accounting standard that governs employee stock options and restricted stock units, companies must measure the fair value of these awards at grant date and recognise the cost as an expense over the vesting period. This transforms the value of employee equity grants from an off-balance-sheet arrangement into a measurable, recurring drag on net income.

The accounting mandate

Before 2006, U.S. companies had a choice: they could recognise stock option grants as an expense on the income statement using the fair-value method, or they could disclose the expense only in footnotes without impacting net income. Nearly all public companies chose the footnote route, making employee equity grants effectively invisible to earnings.

In 2006, the Financial Accounting Standards Board (FASB) mandated ASC 718, requiring all public companies to record stock-based compensation as an expense on the income statement. This brought discipline to equity accounting but also forced companies to confront the true cost of their compensation strategies.

The rule applies to all equity-settled awards: stock options, restricted stock units (RSUs), restricted stock, stock appreciation rights (SARs), and employee stock purchase plans (ESPPs). For any award that gives an employee a chance to own company stock as compensation, the company must measure, record, and expense it.

Grant-date fair value: the core principle

ASC 718 requires companies to measure equity awards at fair value on the grant date. This is non-negotiable. Fair value is the price at which the award would trade between a willing buyer and seller, with no compulsion.

For a restricted stock unit, fair value is straightforward: it’s the stock price on the grant date. If you grant 100 RSUs when the stock is trading at $50, the fair value is $5,000.

For a stock option, fair value is much harder to estimate. The option has no liquid market, so companies must use a valuation model. The most common model is Black-Scholes, which estimates option value based on five inputs:

• Stock price (on grant date)
• Strike price (exercise price)
• Time to expiration (e.g., 10 years)
• Volatility (historical or implied; how much the stock price swings)
• Risk-free interest rate (Treasury yield)

A typical executive grant of 10,000 options at a $50 strike, granted when the stock is $50, with 10-year expiration, 40% volatility, and a 2% risk-free rate, might be valued at $20 per option by Black-Scholes. Total grant-date value: $200,000.

Volatility is the most sensitive input. Higher volatility increases option value because options benefit from large price swings. A volatile startup stock might generate a $30-per-option value; a stable blue-chip might be $12. This is why tech companies and startups (which are more volatile) have much higher option grants: the same economic value requires more options.

Expense recognition over the vesting period

Once fair value is measured, the company recognises the expense over the vesting schedule. If an employee receives a $200,000 option grant that vests evenly over four years, the company expenses $50,000 per year for four years, regardless of whether the stock price rises, falls, or crashes.

This creates an important mismatch: the expense is locked in at grant-date value, but the true economic value to the employee depends on future stock performance. If the stock doubles, the employee receives a windfall, but the company’s expense was calculated years ago and is now understated relative to true economic value. Conversely, if the stock falls 50%, the employee’s grant is worth far less than the company expensed.

Vesting schedules vary but are typically:

• Four-year ratable vesting: 25% per year
• Four-year with one-year cliff: 0% for year 1, then 25% at year 1, then 6.25% per quarter thereafter
• Accelerated schedules: two-year vesting at startups or high-turnover roles

The expense is recognised as an operating cost, usually in departmental cost of revenue or in general and administrative expense, depending on the employee’s role.

Modification and remeasurement

If a company modifies a grant after it’s issued—for example, by changing the strike price, extending the vesting schedule, or lowering the strike price when the stock falls—the company must remeasure the award’s fair value using the new terms.

Remeasurement can be expensive. If you originally granted 10,000 options at a $50 strike when the stock was $50, valued at $200,000, and the stock falls to $30, the options are now underwater (worthless). If you offer to reprice them to $30, the new value might be $150,000. The company must recognise the difference—$50,000—as additional expense.

This makes repricing a costly move from an accounting perspective, which is partly intentional: the rule discourages casual repricing and forces companies to think carefully before adjusting employee grants downward.

Dilution and earnings impact

Stock-based compensation expense is one of the largest operating costs for tech companies. In some years, top tech firms expense $5–10 billion annually in SBC. This is a real economic cost: those shares dilute existing shareholders.

However, SBC expense is often viewed as less real than cash compensation because it does not require cash outflow. A company can have strong cash flow and positive net income even while expensing billions in SBC. Many investors add back SBC to calculate adjusted EBITDA or adjusted net income, treating it as a non-cash item.

This treatment is controversial. Some argue that SBC is real dilution and should not be added back; others argue that for tech companies with high stock valuations, SBC is the efficient way to hire talent, and adding it back is justified. The debate hinges on whether you view equity as a cost or a non-cash accounting nuance.

ASC 718 vs. tax deductions

ASC 718 (accounting) and tax law (for option deductions) operate independently. A company might expense $10 million in SBC for the year but claim only $8 million as a tax deduction, or vice versa.

For non-qualified options, the company gets a tax deduction when the option is exercised, in an amount equal to the spread (fair market value minus strike price) that the employee recognises as ordinary income. For ISOs, the company gets no tax deduction at all if the employee satisfies the holding-period tests.

This difference creates a deferred tax asset or liability on the balance sheet, representing the timing difference between book expense and tax deduction.

Estimating future expense

Analysts often try to forecast future SBC expense, because it’s one of the most controllable (and sometimes opaque) costs. The key variables are:

• Grant quantity: How many shares does the company grant each year?
• Fair value per share: What is the valuation model’s output?
• Vesting schedule: Four-year? Two-year?

A company that grants heavily in years of high stock price will face years of high expense as those grants vest. Conversely, a company that grants lightly will have lower future expense. Understanding the grant history is essential for projecting expense.

Many companies disclose SBC expense in their 10-K and provide details on remaining expense (the unrecognised portion of all outstanding grants), which is called unrecognised compensation cost. This allows investors and analysts to forecast future expense accurately.

See also